glp-1 and acne ✨ Big news… we're now offering GLP-1! ✨ If you've been looking for support on your weight loss journey, this could be your new BFF. 💉🤍 Our team is here to help Dehydrated skin (Concern) Affiliate – SoWell Quantity:30 CT (1 Bottle)

glp-1 and acne ✨ Big news… we're now offering GLP-1! ✨ If you've been looking for support on your weight loss journey, this could be your new BFF. 💉🤍 Our team is here to help Dehydrated skin (Concern) Affiliate – SoWell Quantity:30 CT (1 Bottle)

Affiliate – SoWell

Understanding potential medication conflicts and contraindications empowers you to have informed conversations with your healthcare team

Dehydrated skin (Concern)

Quantity:30 CT (1 Bottle)

Design summary: 3,533 patients with type 2 diabetes and chronic kidney disease CKD inclusion: eGFR 50-75 with UACR 300-5000 mg/g, OR eGFR 25-50 with UACR 100-5000 mg/g Semaglutide 1.0 mg weekly versus placebo Median follow-up: ~3.4 years Primary composite endpoint: kidney failure (initiation of chronic dialysis or kidney transplantation), sustained eGFR decline of ≥50%, kidney-related death, or cardiovascular death Approximate results: Both the kidney-specific outcomes and the cardiovascular outcomes moved in semaglutide's favor with statistical significance